China Pharma Inc. (CPHI)
AMEX: CPHI
· Real-Time Price · USD
1.45
-0.01 (-0.68%)
At close: Aug 15, 2025, 12:38 PM
China Pharma Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -785.57K | -1.22M | -1.12M | -1.44M | -955.89K | -1.23M | -777.6K | -593.03K | -475.98K | -1.26M | -790.77K | -888.39K | -1.03M | -980.72K | -826.67K | -824.76K | -767.33K |
Depreciation & Amortization | 329.31K | 448.07K | 696.94K | 739.25K | 733.8K | 695.84K | 683.09K | 694.84K | 679.88K | 639.42K | 664.34K | 683.21K | 713.56K | 710.72K | 976.46K | 700.46K | 700.19K |
Stock-Based Compensation | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 78.27K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Working Capital | -128.51K | 884.83K | -130.1K | 194.65K | -429.15K | 511.47K | 369.85K | 141.17K | -775.63K | 880.03K | -48.92K | 130.55K | -258.13K | 687.71K | -103.72K | -56.46K | 275.82K |
Other Non-Cash Items | 212.06K | -12.3K | 50.9K | 293.65K | 124.19K | 8.24K | 3.12K | 28.31K | -10.04K | -10.14K | 345.56K | -14.52K | 4.64K | -149.01K | 50.4K | 62.72K | 45.92K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | 186.38K | 1.03M | 323.12K | 332.5K | -487.26K | 505.82K | 1.1M | -346.55K | -1.66M | 1.14M | 419.39K | -114.12K | -568.15K | 220.9K | -651.03K | 737.62K | -255.7K |
Operating Cash Flow | -57.82K | 238.47K | -46.95K | -72.73K | -585.16K | -22.32K | 1.01M | -216.44K | -1.47M | 584.59K | 219.12K | -333.82K | -879.44K | -198.11K | -450.85K | 676.04K | -276.92K |
Capital Expenditures | -80.97K | -272.85K | 9.22K | -28.09K | n/a | -4.53K | n/a | n/a | n/a | -149.41K | -252.55K | -175.29K | -1.39K | -7.06K | -415.98K | -15.02K | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | -22.64K | -253.31K | n/a | n/a | n/a | n/a | -67.45K | 4.5K | 55.96K | 176.68K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | -80.97K | -272.85K | 9.22K | -28.09K | n/a | -4.53K | -67.45K | 4.5K | 55.96K | 27.27K | -252.55K | -175.29K | -1.39K | -7.06K | -415.98K | -15.02K | n/a |
Debt Repayment | -76.82K | 6.8K | 6.84K | 13.71K | n/a | 30.38K | -476.4K | 934.00 | 518.24K | -672.06K | 28.39K | -850.55K | -275.78K | 4.62M | -425.12K | 548.05K | -145.16K |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 6.79K | n/a | n/a | -6.86K | 6.86K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Financial Cash Flow | -70.03K | 6.8K | 6.84K | 6.85K | 6.86K | 30.38K | -476.4K | 934.00 | 518.24K | -672.06K | 28.39K | -850.55K | -275.78K | 4.62M | -425.12K | 548.05K | -145.16K |
Net Cash Flow | -214.19K | -91.81K | -20.65K | -99.54K | -584.96K | 53.97K | 467.96K | -265.04K | -863.02K | -56.33K | -158.66K | -1.47M | -1.14M | 4.4M | -1.3M | 1.22M | -423.12K |
Free Cash Flow | -138.79K | -34.38K | -37.73K | -100.81K | -585.16K | -26.85K | 1M | -216.44K | -1.47M | 435.18K | -33.43K | -509.11K | -880.83K | -205.17K | -866.82K | 661.01K | -276.92K |